Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP940045.RAojocXgIb7dTMxXGfBLYKaAmqnfwsJtG4wf1SGfurbSY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP940045.RAojocXgIb7dTMxXGfBLYKaAmqnfwsJtG4wf1SGfurbSY130_assertion type Assertion NP940045.RAojocXgIb7dTMxXGfBLYKaAmqnfwsJtG4wf1SGfurbSY130_head.
- NP940045.RAojocXgIb7dTMxXGfBLYKaAmqnfwsJtG4wf1SGfurbSY130_assertion description "[Finally, the in�vivo delivery of PU-PEI-miR145 alone significantly suppressed tumorigenesis with stemness, and synergistically improved the survival rate when used in combination with radiotherapy and temozolomide in orthotopic GBM-CD133(+)-transplanted immunocompromised mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP940045.RAojocXgIb7dTMxXGfBLYKaAmqnfwsJtG4wf1SGfurbSY130_provenance.
- NP940045.RAojocXgIb7dTMxXGfBLYKaAmqnfwsJtG4wf1SGfurbSY130_assertion evidence source_evidence_literature NP940045.RAojocXgIb7dTMxXGfBLYKaAmqnfwsJtG4wf1SGfurbSY130_provenance.
- NP940045.RAojocXgIb7dTMxXGfBLYKaAmqnfwsJtG4wf1SGfurbSY130_assertion SIO_000772 22098779 NP940045.RAojocXgIb7dTMxXGfBLYKaAmqnfwsJtG4wf1SGfurbSY130_provenance.
- NP940045.RAojocXgIb7dTMxXGfBLYKaAmqnfwsJtG4wf1SGfurbSY130_assertion wasDerivedFrom befree-2016 NP940045.RAojocXgIb7dTMxXGfBLYKaAmqnfwsJtG4wf1SGfurbSY130_provenance.
- NP940045.RAojocXgIb7dTMxXGfBLYKaAmqnfwsJtG4wf1SGfurbSY130_assertion wasGeneratedBy ECO_0000203 NP940045.RAojocXgIb7dTMxXGfBLYKaAmqnfwsJtG4wf1SGfurbSY130_provenance.